Clinical Trial Update: Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis [Phase 2]

View source ↗

Summary

A Phase 2 study aiming to develop a non-invasive biomarker for monitoring myocardial fibrosis was terminated; the trial involved patients with hypertrophic card…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Hypertrophic Cardiomyopathy

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Hypertrophic Cardiomyopathy, Acute Coronary Syndrome | Phase 2 | Status: TERMINATED